BerandaI9DN • FRA
add
Tekmira Pharmaceuticals
Tutup sebelumnya
€2,92
Rentang hari
€3,13 - €3,18
Rentang tahun
€2,45 - €4,22
Kapitalisasi pasar
687,41Â jt USD
Volume Rata-Rata
259,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,57Â jt | -26,62% |
Biaya operasional | 8,43Â jt | 65,30% |
Laba bersih | -12,53Â jt | 35,11% |
Margin laba bersih | -796,19 | 11,57% |
Penghasilan per saham | -0,10 | 38,71% |
EBITDA | -15,34Â jt | 23,94% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 122,62Â jt | -2,68% |
Total aset | 131,71Â jt | -8,79% |
Total liabilitas | 34,34Â jt | -10,53% |
Total ekuitas | 97,37 jt | — |
Saham yang beredar | 191,48 jt | — |
Harga terhadap nilai buku | 5,73 | — |
Tingkat pengembalian aset | -28,79% | — |
Tingkat pengembalian modal | -36,08% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -12,53Â jt | 35,11% |
Kas dari operasi | -10,32Â jt | 40,35% |
Kas dari investasi | 13,41Â jt | -39,66% |
Kas dari pembiayaan | 1,42Â jt | -62,67% |
Perubahan kas bersih | 4,48Â jt | -48,78% |
Arus kas bebas | -10,96Â jt | -18,93% |
Tentang
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Didirikan
2007
Kantor pusat
Situs
Karyawan
44
